Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production
Partnership will address technical challenges of large-scale, high-efficiency purification of [...]
The Native Antigen Company strengthens senior team to support growing product portfolio
Appointments of Business Development Manager and Senior Product Manager follow [...]
Optibrium appoints Ian Smith as Chief Technology Officer
New role will lead technology development as the Company continues [...]
Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
Fujifilm’s fifth media manufacturing site to be operated by FUJIFILM [...]
The Native Antigen Company introduces new range of influenza antigens
Season-specific Haemagglutinin and Neuraminidase antigens will support vaccine and diagnostic [...]
Bio-Rad Introduces Pioneer™ Antibody Discovery Platform for Therapeutic Development
HERCULES, Calif. — November 14, 2022 — Bio-Rad Laboratories, Inc. [...]
Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft
Microsoft has selected Pangaea to showcase during the HLTH conference [...]
Ubiquigent appoints Dr Hozefa Amijee as Head of Business Development
Appointment will strengthen outsourcing of DUB-focused drug discovery services and [...]
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes
CAMBRIDGE and LEEDS, UK, 03 November 2022 – Optibrium and [...]
The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant
New antigens support research into BA.5 variant, currently responsible for [...]